Staff profiles
Dr Sonya Collins
Data Manager
- Address: Newcastle Clinical Trials Unit
1-4 Claremont Terrace
Newcastle University
Newcastle upon Tyne
NE2 4AE
Background
My background is in virology & cancer research, and I have extensive administrative experience both in the private and public sectors.
In addition to my Data Manager role I also act as Wellbeing Ambassador for the Newcastle Clinical Trials Unit, and I'm one of the many Menopause Champions within the University.
Research
Current Trials:
- Defining microbial predictors of responsiveness to biologic therapies in Crohn’s disease and ulcerative colitis (IBD-RESPONSE)
- COmBining memantine And cholinesterase inhibitors in Lewy body dementia treatment Trial (COBALT)
Previous Trials:
- Minimally invasive thoracoscopoically-guided right minithoracotomy versus conventional sternotomy for mitral valve repair: a multicentre randomised controlled trial (UK Mini Mitral)
- Multicentre, open-label, prospective, single arm study of the safety and impact of Eculizimab withdrawal in patients with atypical haemolytic uraemic syndrome: Stopping Eculizumab Treatment Safely in aHUS (SETS aHUS)
- Obeticholic Acid for the Amelioration of Cognitive Symptoms Trial Programme (OACS-1, OACS-2, OACS-3)
- Prehabilitation in Elective Patients Undergoing Cardiac Surgery: A Randomised Controlled Trial (PrEPS)
- Control, Fludrocortisone or Midodrine for the treatment of Orthostatic Hypotension: A Randomised Controlled Trial (CONFORM-OH)
Publications
-
Articles
- Dominguez-Escrig JL, Kelly JD, Neal DE, King SM, Davies BR. Evaluation of the therapeutic potential of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in preclinical models of bladder cancer. Clinical Cancer Research 2004, 10(14), 4874-4884.
- Patterson SM, Swainsbury R, Routledge EG. Antigen-specific membrane fusion mediated by the haemagglutinin protein of influenza A virus: Separation of attachment and fusion functions on different molecules. Gene Therapy 1999, 6(4), 694-702.